Last updated on February 2017

A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease


Brief description of study

A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

Detailed Study Description

Primary Objective:

  • To compare the pharmacokinetics (PK) of single and multiple doses of IPX203 with Immediate release carbidopa-levodopa (IR CD-LD) in subjects with advanced Parkinson's disease (PD).
Secondary Objectives:
  • To compare the pharmacodynamics of single and multiple doses of IPX203 with IR CD-LD.
  • To compare the efficacy of IPX203 with IR CD-LD following multiple doses.
  • To evaluate the safety of IPX203.

    Clinical Study Identifier: TX147638

    Contact Investigators or Research Sites near you

    Start Over

    Leigh Donharl

    University of South Florida - USF Health Byrd Alzheimer's Institute
    Tampa, FL USA
      Connect »